Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.

Journal of the American Society of Cytopathology - 1 Jan 2000

Sistrunk J Woody, Shifrin Alexander, Frager Marc, Bardales Ricardo H, Thomas Johnson, Fishman Norman, Goldberg Philip, Guttler Richard, Grant Edward

Abstract excerpt

INTRODUCTION: We evaluated the clinical performance of an expanded mutation panel in combination with microRNA classification (MPTX) for the management of indeterminate thyroid nodules. MATERIALS AND METHODS: MPTX included testing of fine-needle aspirates from multiple centers with a combination of ThyGeNEXT mutation panel for strong and weak driver oncogenic changes and ThyraMIR microRNA risk classifier (both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Biopsy, Fine-Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Data Accuracy

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Oncogenes

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Identifiers

PMID: 32247769
DOI: 10.1016/j.jasc.2020.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.PMID 32247769Read ↗

Multiplatform molecular test performance in indeterminate thyroid nodules.Semantic proximity Read ↗

Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.Semantic proximity Read ↗

Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodulesSemantic proximity Read ↗

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.Semantic proximity Read ↗

Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.Semantic proximity Read ↗

A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.Semantic proximity Read ↗

Current State of Molecular Cytology in Thyroid Nodules: Platforms and their Diagnostic and Theranostic UtilitySemantic proximity Read ↗

Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value With Nodule Size.Semantic proximity Read ↗

Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.Semantic proximity Read ↗

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.Semantic proximity Read ↗

ThyroSeq overview on indeterminate thyroid nodules: An institutional experience.Semantic proximity Read ↗

Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.